nach oben

Erschienen in:

01.09.2009 | Clinical Pathology Conference

Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease

A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery

verfasst von: Jessica K. Gordon, MD, Cynthia Magro, MD, Theresa Lu, MD, PhD, Robert Schneider, MD, April Chiu, MD, Richard R. Furman, MD, Garron Solomon, MD, Anne Bass, MD, Doruk Erkan, MD

Erschienen in: HSS Journal ® | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Excerpt

A 33-year-old African-Caribbean man with a history of possible Kikuchi Fujimoto disease (KFD) versus systemic lupus erythematosus (SLE) was evaluated for 3 weeks of fevers to 38.9°C and cough accompanied by fatigue, anorexia, weight loss, diffuse rash, lymphadenopathy, and oral and nasal ulcers. …

Jang YJ, Park KH Seok HJ (2000) Management of Kikuchi’s disease using glucocorticoid. J. Laryngol. Otol. 114:709–11PubMedCrossRef

Rezai K, Kuchipudi S, Chundi V (2004) Kikuchi–Fujimoto disease: hydroxychloroquine as a treatment. Clin. Infect. Dis 39:e124–e126PubMedCrossRef

Lawrence RC, Helmick CG, Arnett FC (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 41:778–799PubMedCrossRef

Jimenez S, Cervera R, Font J (2003) The epidemiology of systemic lupus erythematosus. Clin. Rev. Allergy Immunol. 25:3–12PubMedCrossRef

El-Ramahi KM, Karrar A, Ali MA (1994) Kikuchi disease and its association with systemic lupus erythematosus. Lupus 3:409–11PubMedCrossRef

Goldblatt F, Andrews J, Russell A, Isenberg D (2008) Association of Kikuchi–Fujimoto’s disease with SLE. Rheumatology 47:554–555

Eisner MD, Amory J, Mullaney B (1996) Necrotizing lymphadenitis associated with systemic lupus erythematosus. Semin. Arthritis Rheum. 26:1–6CrossRef

Ohshima K, Karube K, Hamasaki M (2004) Apoptosis- and cell cycle-associated gene expression profiling of histiocytic necrotising lymphadenitis. Eur. J. Haematol. 72:322–9PubMedCrossRef

Kato K, Ohshima K, Anzai K (2001) Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis. Int. J. Hematol. 73:84–6PubMedCrossRef

10.

Kozyrev SV, Lewén S, Reddy PM (2007) Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56:1234–41PubMedCrossRef

11.

Niewold TB, Kelly JA, Flesch MH (2008) Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum. 58:2481–7PubMedCrossRef

12.

Graham RR, Kyogoku C, Sigurdsson S, et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A. 104:6758–6763

13.

Kirou KA, Mavragani CP, Crow MK (2007) Activation of typeI interferon in systemic lupus erythematosus. Expert Rev. Clin. Immunol. 3:579–588

14.

Barrat FJ, Meeker T, Gregorio J, et al. (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202:1131–1139

15.

Cella M, Jarrossay D, Facchetti F (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919–923PubMedCrossRef

16.

Qu C, Moran TM, Randolph GJ (2003) Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. J. Immunol 170:1010–1018PubMed

17.

Tsang WY, Chan JK, Ng CS (1994) Kikuchi’s lymphadenitis. A morphologic analysis of 75 cases with special reference to unusual features. Am. J. Surg. Pathol. 18:219–231PubMedCrossRef

18.

Heremans H, Billiau A, Colombatti A (1978) Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect. Immun. 21:925–930PubMed

19.

Braun D, Geraldes P, Demengeot J (2003) Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20:15–25PubMedCrossRef

20.

Adam C, Thoua Y, Ronco P (1980) The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice. Clin. Exp. Immunol. 40:373–382PubMed

21.

Mathian A, Weinberg A, Gallegos M (2005) IFN-{alpha} induces early lethal lupus in preautoimmune (New Zealand Black × New Zealand White) F1 but Not in BALB/c Mice. J. Immunol. 174:2499–2506PubMed

22.

Santiago-Raber ML, Baccala R, Haraldsson KM (2003) Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice. J. Exp. Med. 197:777–788PubMedCrossRef

23.

Hron JD, Peng SL (2004) Type I IFN protects against murine lupus. J. Immunol. 173:2134–2142PubMed

24.

Baechler EC, Batliwalla FM, Karypis G (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 100:2610–2615PubMedCrossRef

25.

Crow MK, Kirou KA, Wohlgemuth J (2003) Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36:481–490PubMedCrossRef

26.

Bennett L, Palucka AK, Arce E (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711–723PubMedCrossRef

27.

Kirou KA, Lee C, George S (2004) Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 50:3958–3967PubMedCrossRef

28.

Farkas L, Beiske K, Lund-Johansen F (2001) Plasmacytoid dendritic cells (natural interferon- {{alpha}}/{beta}-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159:237–243PubMed

29.

Blomberg S, Eloranta ML, Cederblad B (2001) Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus 10:484–490PubMedCrossRef

30.

Nakano H, Yanagita M, Gunn MD (2001) CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:1171–1178PubMedCrossRef

31.

Yoneyama H, Matsuno K, Toda E (2005) Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 202:425–435PubMedCrossRef

32.

Shiow LR, Rosen DB, Brdickova N, et al., CD69 acts downstream of interferon-[alpha]/[beta] to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006; 440: 540–544.

Titel: Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease
A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery
verfasst von: Jessica K. Gordon, MD
Cynthia Magro, MD
Theresa Lu, MD, PhD
Robert Schneider, MD
April Chiu, MD
Richard R. Furman, MD
Garron Solomon, MD
Anne Bass, MD
Doruk Erkan, MD
Publikationsdatum: 01.09.2009
Verlag: Springer-Verlag
Erschienen in: HSS Journal ® / Ausgabe 2/2009
Print ISSN: 1556-3316
Elektronische ISSN: 1556-3324
DOI: https://doi.org/10.1007/s11420-009-9123-x

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Internistische Arzneimitteltherapie Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease

A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery

Excerpt

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Fehlerkultur in der Medizin – Offenheit zählt!

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Update Orthopädie und Unfallchirurgie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2009

Cryosurgery and Impaction Subchondral Bone Graft for the Treatment of Giant Cell Tumor Around the Knee

Spontaneous Posterior Iliac Crest Regeneration Enabling Second Bone Graft Harvest; A Case Report

Does Shoe Insole Modification Prevent Stress Fractures? A Systematic Review

Percutaneous CT-Guided Treatment of Lumbar Facet Joint Synovial Cysts

Is There a Role for NFAT Inhibitors in the Prevention of Bone Destruction?

Total Hip Arthroplasty in Rapidly Destructive Osteoarthritis of the Hip: A Case Series

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Fehlerkultur in der Medizin – Offenheit zählt!

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Update Orthopädie und Unfallchirurgie